Interfering RNA duplex having bluntends and 3'-modifications

Details for Australian Patent Application No. 2004269150 (hide)

Owner Novartis AG

Inventors Natt, Francois Jean-Charles; Haner, Robert; Hall, Jonathan; Weiler, Jan; Bologna, Jean-Charles

Agent Davies Collison Cave

Pub. Number AU-B-2004269150

PCT Pub. Number WO2005/021749

Priority 60/498,514 28.08.03 US

Filing date 27 August 2004

Wipo publication date 10 March 2005

Acceptance publication date 4 June 2009

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

2 March 2006 PCT application entered the National Phase

  PCT publication WO2005/021749 Priority application(s): WO2005/021749

4 June 2009 Application Accepted

  Published as AU-B-2004269150

1 October 2009 Standard Patent Sealed

1 July 2010 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 21 May 2010. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

18 November 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 21 May 2010

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004269152-Method for detoxification of mycotoxins

2004269148-Energy recovery system